These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group. Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F; Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027 [TBL] [Abstract][Full Text] [Related]
4. A cautious use of sodium cellulose phosphate in the management of calcium nephrolithiasis. Pak CY Invest Urol; 1981 Nov; 19(3):187-90. PubMed ID: 7298289 [TBL] [Abstract][Full Text] [Related]
5. Effect of a 5-year treatment program in patients with hyperoxaluric stones. Pinto B; Ruiz-Marcellán FJ; Bernshtam J J Urol; 1983 Nov; 130(5):943-5. PubMed ID: 6632105 [TBL] [Abstract][Full Text] [Related]
6. New drug therapy for kidney stones: a review of cellulose sodium phosphate, acetohydroxamic acid, and potassium citrate. Lake KD; Brown DC Drug Intell Clin Pharm; 1985; 19(7-8):530-9. PubMed ID: 3896714 [TBL] [Abstract][Full Text] [Related]
7. Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Bushinsky DA; Asplin JR; Grynpas MD; Evan AP; Parker WR; Alexander KM; Coe FL Kidney Int; 2002 Mar; 61(3):975-87. PubMed ID: 11849452 [TBL] [Abstract][Full Text] [Related]
8. Evaluation and medical management of the patient with calcium stone disease. Menon M; Krishnan CS Urol Clin North Am; 1983 Nov; 10(4):595-615. PubMed ID: 6636376 [TBL] [Abstract][Full Text] [Related]
9. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats]. Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444 [TBL] [Abstract][Full Text] [Related]
10. Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers. Seeger H; Kaelin A; Ferraro PM; Weber D; Jaeger P; Ambuehl P; Robertson WG; Unwin R; Wagner CA; Mohebbi N BMC Nephrol; 2017 Dec; 18(1):349. PubMed ID: 29202723 [TBL] [Abstract][Full Text] [Related]
11. Effect of hyperprotidic diet associated or not with hypercalcic diet on calcium oxalate stone formation in rat. Sakly R; Bardaoui M; Neffati F; Moussa A; Zakhama A; Najjar MF; Hammami M Ann Nutr Metab; 2005; 49(2):132-8. PubMed ID: 15860912 [TBL] [Abstract][Full Text] [Related]
12. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. Fetner CD; Barilla DE; Townsend J; Pak CY J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659 [TBL] [Abstract][Full Text] [Related]
13. Effects of high intake of dietary animal protein on mineral metabolism and urinary supersaturation of calcium oxalate in renal stone formers. Fellström B; Danielson BG; Karlström B; Lithell H; Ljunghall S; Vessby B; Wide L Br J Urol; 1984 Jun; 56(3):263-9. PubMed ID: 6544608 [TBL] [Abstract][Full Text] [Related]
14. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein. Schwille PO; Schmiedl A; Manoharan M Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561 [TBL] [Abstract][Full Text] [Related]
15. Resorptive and absorptive hypercalciuria. Therapy with sodium cellulose phosphate or thiazides. Hering F; Lutzeyer W Eur Urol; 1979; 5(1):29-31. PubMed ID: 428408 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of recurrent nephrolithiasis (calcium stones) with cellulose phosphate. Pak CY; Delea CS; Bartter FC N Engl J Med; 1974 Jan; 290(4):175-80. PubMed ID: 4808916 [No Abstract] [Full Text] [Related]
19. The urinary excretion and serum concentration of calcium, magnesium, sodium and phosphate in male patients with recurring renal stone formation. Jorgensen FS Scand J Urol Nephrol; 1975; 9(3):243-8. PubMed ID: 1209181 [TBL] [Abstract][Full Text] [Related]
20. Calcium oxalate stone disease: effects and side effects of cellulose phosphate and succinate in long-term treatment of absorptive hypercalciuria or hyperoxaluria. Hautmann R; Hering FJ; Lutzeyer W J Urol; 1978 Dec; 120(6):712-5. PubMed ID: 731812 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]